Corvid Biolabs

Startup · Synthetic biology

—

insufficient evidence

ScreeningUnknown · Evidence pack incomplete — 3 of 6 signal families unpopulated

✓ Evidence convergence: 2 corroborating families (2+ required)○ Adversarial review not-started✓ 0 unresolved critical contradictionscvd-corvid-2026-08-21-01 · conviction-policy 1.0

Promotion blocked: Traction and risk families unpopulated; pre-revenue with no public repositories.

Dossier not yet generated

This candidate is in the screening tier. A full dossier (theses, evidence, skeptic review) is produced when the research orchestrator promotes it — no model run has been scheduled yet.

quality: 71 of 100 — independently corroborating
growth: unknown — No traction proxies; pre-revenue, no public repositories
valuation: unknown — No financing terms beyond Form D total offering
ownership: 64 of 100 — independently corroborating
catalysts: 59 of 100
risk: unknown — Key-person and IP assignments not yet verified

Conviction governance